ArticleJournal of the National Cancer Institute2013

Combating resistance to anti-IGFR antibody by targeting the integrin β3-Src pathway.

Dong Hoon Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.